Alerts will be sent to your verified email
Verify EmailSMSPHARMA
SMS Pharmaceuticals
|
Morepen Laboratories
|
Solara Active Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
2.4 % | 0.87 % | n/a |
Financials
|
|||
5 yr Average ROE
|
9.06 % | 13.43 % | -10.41 % |
5yr average Equity Multiplier
|
1.9 | 1.68 | 1.99 |
5yr Average Asset Turnover Ratio
|
0.64 | 1.29 | 0.54 |
5yr Avg Net Profit Margin
|
7.28 % | 5.93 % | -7.28 % |
Price to Book
|
4.28 | 2.57 | 2.98 |
P/E
|
37.45 | 32.04 | 132.81 |
5yr Avg Cash Conversion Cycle
|
93.25 Days | 12.78 Days | 28.67 Days |
Inventory Days
|
116.73 Days | 54.64 Days | 111.94 Days |
Days Receivable
|
93.46 Days | 65.45 Days | 95.97 Days |
Days Payable
|
85.64 Days | 96.29 Days | 146.85 Days |
5yr Average Interest Coverage Ratio
|
4.77 | 39.11 | 0.25 |
5yr Avg ROCE
|
12.12 % | 15.77 % | 2.1 % |
5yr Avg Operating Profit Margin
|
17.98 % | 8.68 % | 9.63 % |
5 yr average Debt to Equity
|
0.53 | 0.04 | 0.7 |
5yr CAGR Net Profit
|
9.56 % | 3.98 % | -69.98 % |
5yr Average Return on Assets
|
4.75 % | 7.67 % | -3.67 % |
Shareholdings
|
|||
Promoter Holding
|
66.26 % | 35.65 % | 42.01 % |
Share Pledged by Promoters
|
32.49 % | 0.0 | 38.95 % |
Change in Promoter Holding (3 Yrs)
|
2.09 % | -1.09 % | 1.61 % |
Change in Mutual Fund Holding (3 Yrs)
|
3.03 % | 0.0 | -1.56 % |
SMS Pharmaceuticals
|
Morepen Laboratories
|
Solara Active Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|